Current evidences indicate that both inflammation and oxidative stress contribute to the pathogenesis of sepsis‐associated skeletal muscle atrophy. However, the interaction between inflammation and oxidative stress has not been completely understood in sepsis‐associated skeletal muscle atrophy. Here in the present study, a murine model of sepsis has been established by cecal ligation and puncture (CLP) with wild‐type and interleukin‐ (IL‐) 6 knockout (KO) mice. Our results suggested that IL‐6 KO largely attenuated skeletal muscle atrophy as reflected by reduced protein degradation, increased cross‐sectional area (CSA) of myofibers, and improved muscle contractile function (all P < 0.05). In addition, we observed that IL‐6 KO promoted the expression of peroxisome proliferator‐activated receptor γ coactivator–1alpha (PGC–1α) and inhibited CLP‐induced mitochondrial reactive oxygen species (ROS) production in skeletal muscles (all P < 0.05). However, the knockdown of PGC–1α abolished the protective effects of IL‐6 KO in CLP‐induced skeletal muscle atrophy and reversed the changes in mitochondrial ROS production (all P < 0.05). Ex vivo experiments found that exogenous IL‐6 inhibited PGC–1α expression, promoted mitochondrial ROS production, and induced proteolysis in C2C12 cells (all P < 0.05). Together, these results suggested that IL‐6 deficiency attenuated skeletal muscle atrophy by inhibiting mitochondrial ROS production through the upregulation of PGC–1α expression in septic mice.
24 January 2024 in Chemico-Biological Interactions
Tylophorine analogs have been shown to exhibit diverse activities against cancer, inflammation, arthritis, and lupus in vivo. In this study, we demonstrated that two tylophorine analogs, DCB-3503 and rac-cryptopleurine, exhibit potent inhibitory activity against hepatitis C virus (HCV) replication in genotype 1b Con 1 isolate. The inhibition of HCV replication is at least partially mediated through cellular heat shock cognate protein 70 (Hsc70). Hsc70 associates with the HCV replication complex by primarily binding to the poly U/UC motifs in HCV RNA. The interaction of DCB-3503 and rac-cryptopleurine with Hsc70 promotes the ATP hydrolysis activity of Hsc70 in the presence of the 3′ poly U/UC motif of HCV RNA. Regulating the ATPase activity of Hsc70 may be one of the mechanisms by which tylophorine analogs inhibit HCV replication. This study demonstrates the novel anti-HCV activity of tylophorine analogs. Our results also highlight the importance of Hsc70 in HCV replication.
Swainsonine is an Astragalus membranaceus extract. It is indole, alkaloid, and soluble in water. Its effect on rat cardiomyocytes apoptosis, and the mechanisms underlying that effect, were investigated by inducing apoptosis in H9c2 cells. This was detected by MTT assay, Annexin V-FITC/propidium iodide double staining and western blotting. Flow cytometry and fluorescence microscopy were used to confirm swainsonine's effect on mitochondrial membrane potential and levels of reactive oxygen species, while an ATP-dependent bioluminescence assay kit served to find the ATP contents. Assessment was also carried out for peroxisome proliferator activated receptor γ co-activator 1α (PGC-1α) expression levels as well as those of such apoptosis-associated proteins as Cytochrome c, Caspase-3, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax). Overall, indications were that swainsonine may have the potential to inhibit viability of cells, decrease expression of PGC-1α, induce mitochondrial dysfunction, upregulate Cytochrome c, Bax and Caspase-3, and downregulate Bcl-2. The suggestion would be that apoptosis may be induced through signalling pathways in H9c2 cells mediated by mitochondria.
Background Osteoarthritis (OA), the most common type of arthritis, is a highly prevalent age-related joint disease particularly in subjects over 65 years old. The chronic rise of senescent cells closely correlates with age-related diseases including OA, and the senescence-associated secretory phenotype (SASP) is implicated in the pathogenesis of OA cartilage degeneration. Sirtuin 6 (SIRT6) is probable to be a key senescence-related regulator. Fisetin (FST), a natural flavonol of the flavonoid family, is recommended to be a senolytic that extends health and lifespan. However, the potential chondroprotective effects of FST on OA rats remain largely unclarified. This study aimed to investigate the ameliorative effects of FST on OA joint cartilage and the relationship with SIRT6, and the detailed mechanisms from both anti-inflammatory and anti-senescent perspectives. Methods Rats were subjected to destabilization of the medial meniscus (DMM) surgery to induce the experimental OA model in vivo. Chondrocytes treated with IL-1β were utilized to mimic the OA cell model in vitro. Intra-articular injection of FST, OSS_128167 (OSS, SIRT6 inhibitor), and MDL800 (MDL, SIRT6 agonist) in vivo or incubation with IL-1β-induced rat chondrocytes in vitro were performed to determine the effects of FST on OA and the link with SIRT6. Results SIRT6 level was negatively correlated with OA severity. SIRT6 downregulation was validated in joint cartilages of DMM rats and IL-1β-treated chondrocytes. Of note, We demonstrated FST could activate SIRT6. Both the administration of FST and activation of SIRT6 using MDL rescued cartilage erosion, decreased extracellular matrix (ECM) degradation, prevented cartilage from apoptosis, and improved detrimental senescence-related phenotype. The alleviative effects of FST against inflammation, ECM degradation, apoptosis, and senescence were also confirmed in IL-1β-stimulated chondrocytes. Conclusion SIRT6 loss occurs in articular cartilage in the pathogenesis of OA, which is linked to aging. FST attenuates injury-induced aging-related phenotype changes in chondrocytes by targeting SIRT6.